iSpecimen Inc. (ISPC)

USD 3.95

(18.98%)

Gross Profit Summary of iSpecimen Inc.

  • iSpecimen Inc.'s latest annual gross profit in 2023 was 5.1 Million USD , down -46.11% from previous year.
  • iSpecimen Inc.'s latest quarterly gross profit in 2024 Q2 was 832.54 Thousand USD , up 20.08% from previous quarter.
  • iSpecimen Inc. reported a annual gross profit of 5.64 Million USD in annual gross profit 2022, down -4.09% from previous year.
  • iSpecimen Inc. reported a annual gross profit of 5.88 Million USD in annual gross profit 2021, up 28.0% from previous year.
  • iSpecimen Inc. reported a quarterly gross profit of 693.29 Thousand USD for 2024 Q1, up 13.55% from previous quarter.
  • iSpecimen Inc. reported a quarterly gross profit of 610.58 Thousand USD for 2023 Q4, down -55.92% from previous quarter.

Annual Gross Profit Chart of iSpecimen Inc. (2023 - 2018)

Historical Annual Gross Profit of iSpecimen Inc. (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 5.1 Million USD -46.11%
2022 5.64 Million USD -4.09%
2021 5.88 Million USD 28.0%
2020 4.59 Million USD 111.87%
2019 2.17 Million USD 6.8%
2018 2.03 Million USD 0.0%

Peer Gross Profit Comparison of iSpecimen Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 46.603%
Prenetics Global Limited 8.82 Million USD 42.152%
Star Equity Holdings, Inc. 11.92 Million USD 57.17%
CareDx, Inc 178.32 Million USD 97.136%
Exact Sciences Corporation 1.84 Billion USD 99.723%
Exagen Inc. 29.45 Million USD 82.659%
Inotiv, Inc. 165.44 Million USD 96.913%
Guardant Health, Inc. 336.89 Million USD 98.484%
Biodesix, Inc. 36.07 Million USD 85.842%
BioNexus Gene Lab Corp. 1.32 Million USD -284.199%
Precipio, Inc. 6.01 Million USD 15.123%
Natera, Inc. 492.74 Million USD 98.963%
Aspira Women's Health Inc. 5.26 Million USD 2.928%
Standard BioTools Inc. 50.45 Million USD 89.875%
23andMe Holding Co. 99.37 Million USD 94.86%
Castle Biosciences, Inc. 174.8 Million USD 97.078%
Personalis, Inc. 18.2 Million USD 71.947%
Aclaris Therapeutics, Inc. 13.16 Million USD 61.21%
Applied DNA Sciences, Inc. 5.53 Million USD 7.69%
OpGen, Inc. -90.69 Thousand USD 5732.033%
T2 Biosystems, Inc. -8.17 Million USD 162.52%
Myriad Genetics, Inc. 476.4 Million USD 98.928%
ICON Public Limited Company 1.81 Billion USD 99.718%
NeoGenomics, Inc. 244.6 Million USD 97.912%
Star Equity Holdings, Inc. 11.92 Million USD 57.17%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.767%
RadNet, Inc. 93 Million USD 94.508%
MDxHealth SA 43.92 Million USD 88.372%
Psychemedics Corporation 8.41 Million USD 39.285%
Illumina, Inc. 2.74 Billion USD 99.814%
Check-Cap Ltd. -212 Thousand USD 2509.394%
Twist Bioscience Corporation 133.34 Million USD 96.17%
DarioHealth Corp. 5.98 Million USD 14.64%
Fulgent Genetics, Inc. 104.45 Million USD 95.11%
Sera Prognostics, Inc. 96 Thousand USD -5220.746%
ENDRA Life Sciences Inc. -275.45 Thousand USD 1954.383%
OPKO Health, Inc. 318.12 Million USD 98.394%
Medpace Holdings, Inc. 524.5 Million USD 99.026%
Neogen Corporation 463.9 Million USD 98.899%
Intelligent Bio Solutions Inc. 1.42 Million USD -258.293%
Prenetics Global Limited 8.82 Million USD 42.152%
Mainz Biomed B.V. 509.65 Thousand USD -902.222%
bioAffinity Technologies, Inc. 791.61 Thousand USD -545.253%
Trinity Biotech plc 19.45 Million USD 73.738%
Neuronetics, Inc. 51.7 Million USD 90.121%
Sotera Health Company 577.15 Million USD 99.115%
bioAffinity Technologies, Inc. 791.61 Thousand USD -545.253%